![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1800976
À̽ÄÇü °ñÀüµµ º¸Ã»±â(BAHA) ½ÃÀå º¸°í¼ : ¿øÀç·á, ³Ã» À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)Bone Anchored Hearing Aids Market Report by Raw Material, Hearing Loss Type, End User, and Region 2025-2033 |
À̽ÄÇü °ñÀüµµ º¸Ã»±â(BAHA) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 1,500¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 5¾ï 8,260¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6.72%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.
À̽ÄÇü °ñÀüµµ º¸Ã»±â(BAHA)´Â ´Ù¾çÇÑ À¯ÇüÀÇ ³Ã»À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â ¿Ü°úÀû À̽ÄÇü º¸Ã»±âÀÔ´Ï´Ù. ±Í µÚÂÊ À¯¾çµ¹±â »À¿¡ ƼŸ´½ ³ª»ç°¡ °íÁ¤µÇ¾î ÀÖ°í, ¾î¹öÆ®¸ÕÆ®¸¦ ÅëÇØ ¼ÒÇü Å»Âø½Ä »ç¿îµå ÇÁ·Î¼¼¼¿¡ ¿¬°áµÇ¾î ÇǺΠÀÓÇÇ´ø½º¿Í ÇÇÇÏÁ¶Á÷À» ¿ìȸÇÏ¿© ³»ÀÌ¿¡ Á÷Á¢ ¼Ò¸®¸¦ Àü´ÞÇÕ´Ï´Ù. ±âÁ¸ º¸Ã»±â¿¡ ºñÇØ ´õ ³ªÀº À½Áú°ú Æí¾ÈÇÔÀ» Á¦°øÇÕ´Ï´Ù. BTE(±Í°ÉÀÌÇü º¸Ã»±â)¿¡ ºñÇØ ÇǺΠÀÚ±ØÀÌ ¾ø°í, ¿¡³ÊÁö ¼Ò¸ð°¡ ÀûÀ¸¸ç, ±Í¿¡ °Å½½¸®´Â ¼Ò¸®¸¦ ÁÙÀÏ ¼ö ÀÖ¾î Àü ¼¼°èÀûÀ¸·Î ÆíÃø ³Ã», ÀüÀ½¼º ³Ã», È¥ÇÕ¼º ³Ã»À» °¡Áø ¾î¸°ÀÌ¿Í ¼ºÀο¡°Ô ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.
°í·ÉÈ¿¡ µû¶ó û°¢ Àå¾Ö ¹ß»ý À§ÇèÀÌ ³ô¾ÆÁö±â ¶§¹®¿¡ ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¼Ò¾Æ°ú¿¡¼ ³Ã» »ç·Ê°¡ Áõ°¡ÇÏ°í ¼ö¼úÀÇ À§Ç輺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¦ÇÑµÈ ±â°£ µ¿¾È ºñ¼ö¼úÀû ÇØ°áÃ¥À¸·Î ÀÛ¿ëÇÏ´Â ¼ÒÇÁÆ® ¹êµå BAHA¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠ±¹°¡ÀÇ ÇàÁ¤ ±â°üÀº ½Å»ý¾Æ¿¡°Ô ³Ã» ¼±º° °Ë»ç¸¦ Àǹ«ÈÇÏ´Â ±ÔÁ¤°ú ±ÔÁ¤À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ´õ ³ªÀº º¸Çè ȯ±Þ °¡´É¼º°ú ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ·Îº¿ Ç÷§Æû°ú ¼ö¼ú ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº BAHA ¼ö¼úÀÇ ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ Àü ¼¼°èÀûÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷µéÀº ¶ÇÇÑ ¼ÒºñÀÚÃþÀ» È®´ëÇϱâ À§ÇØ Ã·´Ü Á¦Ç°À» Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, º¸Ã»±â¸¦ Á¦Á¶ÇÏ´Â ¸Þµå¿¤Àº ADHEAR¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ºñÀÓÇöõÆ®Çü BAHA ÀåÄ¡´Â ¸ðµç ¿¬·É´ë¿¡ ÀûÇÕÇϸç, Æí¾ÈÇÑ Ã»·Â°ú ¾ÈÁ¤ÀûÀΠû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
The global bone anchored hearing aids market size reached USD 315.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 582.6 Million by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033.
A bone anchored hearing aid (BAHA) is a surgical, implantable device used to treat individuals with different types of hearing loss. It has a titanium screw anchored to the mastoid bone behind the ear, which is connected to a small detachable sound processor through an abutment that propagates sound directly to the inner ear, bypassing skin impedance and subcutaneous tissues. It provides better sound quality and greater comfort compared to conventional hearing devices. Compared to the BTE (behind-the-ear hearing aids), it does not cause skin irritation, requires less energy, reduces aural discharge, and is gaining traction worldwide among children and adults with single-sided deafness and conductive or mixed hearing loss.
As the risk of developing hearing impairment increases with age, the rising geriatric population represents one of the key factors bolstering the market growth. Moreover, the growing instances of hearing loss in pediatrics, along with the high risk of surgery, are escalating the demand for soft band BAHA that acts as a non-surgical solution for a limited period. Additionally, governing agencies of several countries are implementing rules and regulations that require neonates to be screened for hearing loss. This trend, along with the availability of better reimbursement coverage, is impacting the market growth positively. Apart from this, robotic platforms and surgical navigation systems are gaining popularity around the world to reduce BAHA surgical complications. The market players are also introducing advanced products to expand their consumer base. For instance, MED-EL, a company that manufactures hearing implants, launched ADHEAR. This non-implanted BAHA device is suitable for all ages and provides effortless hearing and reliable listening.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Auditdata A/S, Cochlear Ltd., Demant A/S, GN Hearing A/S (GN Store Nord A/S), Natus Medical Incorporated, Sonova Holding AG, Starkey Hearing Technologies and Widex A/S.